Ivory plans to strengthen the technology for its clinical grade assessments and scale distribution to reach more individuals across India
Ivory, an early-stage brain health startup, has announced the successful close of its latest $1 million funding round. The round was co-led by IIM-A Ventures, the entrepreneurship centre at IIM Ahmedabad that incubates, accelerates and invests in early-stage technology startups, and Capital-A, a fund known for backing innovative early-stage startups, which had previously backed Ivory in the pre-seed stage.
The funding round saw additional backing from 1Crowd, and Stanford Angels, along with angel investors such as Dr Sanjay Arora, Adarsh Narahari and Juhi Bhatnagar.
With this new capital, Ivory plans to strengthen the technology for its clinical grade assessments and scale distribution to reach more individuals across India.
Rahul Krishnan, Co-founder and CPO, Ivory said, “With this capital, we aim to further invest in our technology—enhancing the accuracy, depth and reach of our cognitive assessments. As conversations around longevity and preventive health gain momentum, Ivory stands at the intersection of technology, healthcare and ageing to reshape how we approach long-term brain wellness.”
Furthermore, Issac John, Co-Founder and CEO added, “At Ivory, we are building for a future where brain health is prioritized just like physical health. As people move into their 40s and beyond, Ivory’s early detection and intervention-led approach towards cognitive risks will play a pivotal role in reducing society’s healthcare burden.”
Speaking about the investment, Vipul Patel, Partner, IIM-A Ventures said "Of the four horsemen of chronic illness, neurodegenerative diseases remain the least understood and most difficult to reverse. Ivory’s vision to bring early, accessible cognitive screening into everyday preventive health is both timely and essential. Ivory's ability to marry clinical depth with an engaging consumer experience is commendable, which is also something this space has lacked. As Medicine 3.0 shifts focus from reactive treatment to proactive prevention, we believe Ivory can define how cognitive care fits into everyday health decisions."
Ankit Kedia, Founder & Lead Investor, Capital-A added “There is a growing awareness that brain health is a core pillar of preventive care and yet solutions remain limited. Ivory is bringing a data-led, clinically grounded platform to the table, and we believe their work will play a crucial role in shaping the future of ageing and mental wellness.”
Looking ahead, the team plans to expand its footprint across new geographies, deepen AI capabilities to personalise assessments further, and invest in longitudinal research to build benchmarks for cognitive health specific to Indian populations. Ivory is building the future of brain health through science-backed, accessible, tech-first solutions.
